4YJ-24496-51893
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 554 / MN
- Registered
- 2022-09-17
- Relationship
- Child or adolescent in my care
- Guardian
- ANY-91865-66520
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-24
Dose 1 — Moderna
-
2022-09-17
Registered in v-safe
-
2022-09-21
Dose 2 — ModernaCo-administered: Flu
-
2022-09-22
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Site: Pain · Fever · Chills, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-30
-
2022-10-07
Survey response — day 14, dose 2, dependentMedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: FairFree text: Cold - cough and runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-19
- 2022-10-26
- 2022-11-04
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-24 | Moderna | No |
| 2 | 2022-09-21 | Moderna | Flu |
Free text
Release 12 — day 14, dose 2, dependent
Symptoms: Cold - cough and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release